期刊文献+

福辛普利联合氯沙坦对慢性心力衰竭患者心室重构及NT-proBNP水平的影响 被引量:1

下载PDF
导出
摘要 目的:观察联合应用福辛普利与氯沙坦对于老年慢性心力衰竭患者心室重构及NT-proBNP水平的影响。方法:将患者随机分为实验组及对照组。在治疗前后测定LVESd、LVEDd、LVEF及NT-proBNP浓度。结果:实验组LVESd、LVEDd下降显著,LVEF明显增加,与对照组比较差异有显著性(P<0.05)。结论:联合应用福辛普利与氯沙坦能更好地改善左室重构、降低血浆BNP水平。
作者 赵雅琳 姚宇
出处 《中国误诊学杂志》 CAS 2008年第22期5313-5314,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

  • 1赵洁,陈绍行,顾天华.血管紧张肽转换酶抑制剂与血管紧张肽II受体拮抗剂的联合应用[J].中国新药与临床杂志,2004,23(6):368-372. 被引量:14
  • 2Catuzzo B,Ciancamerla F,Bobbio N,et al. In patients with severe systolic dysfunction,only brain natriuretic peptide is related to diastolic restrictive pattern[J]. J Card Fail, 2003,9 (4) : 303-311.
  • 3Yasumura Y,Miyatake K,Okamoto H,et al. Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin Ⅱ receptor blocker therapy in heart failure [J]. Circ J, 2004,68(4) : 361-366.

二级参考文献28

  • 1RUILOPE LM, ALDIGIER JC, PONTICELLI C,et al. Safety of the combination of valsartan and benazepril in patients with chronic renal disease[J]. J Hypertens, 2000,18 (1) :89-95.
  • 2MOGENSEN CE, NELDAM S, TIKKANEN I, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria(CALM) s
  • 3McKELVIE RS,YUSUF S, PERICAK D, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD)pilot study. The RESOLVD Pilot Study Investigator
  • 4WONG M, STASZEWSKY L, LATINI R, et al. Valsartan benefits left ventricular structure and function in heart failure: ValHeFT echocardiographic study[J]. J Am Coll Cardiol, 2002 ,40(5) :970-975.
  • 5VIZIR VA,BEREZIN AE. Effect of long-term treatment with enalapril,losartan and their combination on the quality of life of patients with congestive heart failure[J]. Ter Arkh (in Russian),2002,74(1):52-55.
  • 6AZIZI M,LINHART A, ALEXANDER J, et al. Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients [J]. J Hypertens , 2000,18 (8):1139-1147.
  • 7WEIR MR,WEBER MA,NEUTEL JM, et al. Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy:a clinical experience trial. ACTION study investigators[J]. Am J Hypertens , 2001,14 (6 Pt 1): 567-572.
  • 8TAAL MW,BRENNER BM. Combination ACEI and ARB therapy: additional benefit in renoprotection? [J] . Curr Opin Nephrol Hypertens, 2002,11 (4): 377-381.
  • 9RUSSO D, PISANI A,BALLETTA MM, et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy [J]. Am J Kidney Dis, 1999,33 (5) :851-856.
  • 10BERGER ED, BADER BD, EBERT C, et al. Reduction of proteinuria;combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition[J]. J Hypertens, 2002,20(4): 739-743.

共引文献13

同被引文献3

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部